Drug Discovery Contract Work
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
22
NCT04046250
Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690
Phase: Phase 2
Role: Collaborator
Start: May 15, 2019
Completion: Mar 31, 2020
Loading map...